Identifying the Short-Term Neurobiological, Metabolic and Behavioural Effects of CONTRAVE As Potential Mechanisms of Weight Loss in Adults with Obesity: a Randomized, Double-Blind, Placebo-Controlled Pilot Trial
Latest Information Update: 26 Mar 2025
At a glance
- Drugs Naltrexone/bupropion (Primary)
- Indications Obesity
- Focus Therapeutic Use
Most Recent Events
- 10 Feb 2025 New trial record